Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mangalam Drugs & Organics is a prominent Indian pharmaceutical company primarily engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is recognized as a leading global supplier in the anti-malarial segment, producing key ingredients such as artemether and lumefantrine. In addition to its core anti-malarial portfolio, Mangalam produces treatments for HIV/AIDS, cardiovascular diseases, and metabolic disorders. Its manufacturing facilities in Vapi, Gujarat, are compliant with international standards, including WHO-GMP certifications. The company plays a vital role in global health supply chains, partnering with international agencies to provide affordable essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mangalam Drugs & Organics.